Senators Target Abuse in 340B Drug Discount Plan

Is a massive drug discount program helping patients or boosting hospital profits? Senators grilled experts on the $66 billion 340B program, meant to lower drug costs for the poor, amid concerns it's spiraling out of control. Discover how this program exploded tenfold, why some say it incentivizes pricey prescriptions and hospital acquisitions, and whether reforms could save taxpayers billions or devastate rural healthcare. The Daily News Now! - Every city. Every story. AI Powered. Hosted on Acast. See acast.com/privacy for more information.